NINDS to Fund Biomarker ID, Assay Optimization Studies for Parkinson's Disease | GenomeWeb

NEW YORK (GenomeWeb) – The National Institute of Neurological Disorders and Stroke will support research projects to discover and use biomarkers for Parkinson's disease, NINDS said in a new funding announcement on Monday.

NINDS plans to provide between $200,000 and $490,000 for two-to-three-year studies to discover biomarkers, optimize biomarker-based assays, and develop these tools further through replication studies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.